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Fever continues to be a leading cause of visits in both primary care offices and the emergency room. It is thought to be present in 19 to 30% of all office encounters in primary care settings [1] . The evaluation and initial treatment of infants and children with fever is often debated. This article focuses on the recent literature surrounding the etiology, pathophysiology, diagnostic tools for evaluation, and treatment of infants and children with fever.
Evaluating serious bacterial infection
The concern for many pediatricians whose patients present with fever is that of serious bacterial infection (SBI), including meningitis, bacteremia, urinary tract infections (UTIs), and bacterial gastroenteritis. The risk of SBI is variable depending on the age of the patient; standard divisions are younger than 1 month, 1 to 3 months, and older than 3 months. Previous studies performed in the emergency room setting have estimated the incidence of bacterial disease to be approximately 10% in febrile infants 1 to 2 months of age and approximately 13% in febrile infants younger than 1 month [2] . Other studies have estimated the range to be 6 to 10% in infants younger than 2 months [3] . The higher incidence of bacterial disease in this age group is likely related to lower levels of immune function, including decreased opsonin activity, macrophage function, and neutrophil activity. Because the physical examination is limited in children younger than 3 months, screening tools are extremely important in identifying patients at risk for SBI.
Two prospective studies have been conducted to test the safety and efficacy of outpatient treatment of fever in infants between 1 and 3 months. The first investigation was performed in the emergency room at Children's Hospital, Boston [4] . Febrile infants aged between 1 and 3 months who were deemed to be at low risk for bacterial disease were discharged home after receiving intramuscular ceftriaxone. In this study, 336 febrile infants aged between 1 and 2 months and 167 infants aged between 2 and 3 months were judged to be at low risk for bacterial disease by using the following criteria: physical examination findings of an infant who appears well; laboratory evaluation, including normal cerebrospinal fluid (fewer than 10 leukocytes per cubic millimeter [WBC/mm 3 ]); urinalysis with fewer than 10 leukocytes per high-powered field; a chest radiograph with no infiltrate; and a leukocyte count of fewer than 20,000 WBC/mm 3 . Of these infants, 27 (5%) had culture-positive disease, including bacteremia, UTI, and gastroenteritis. When the two groups were compared, infants with bacterial disease were not discernable from those without bacterial disease. Infants in both groups did well clinically.
The second prospective study was performed at Children's Hospital of Philadelphia [1] . Antibiotics were selectively withheld from a group of febrile infants who were judged to be at low risk for bacterial disease. Of the 747 infants aged between 1 and 3 months who presented with fever, 287 (39.4%) were judged to be low risk for bacterial disease. The screening tools used in this study were an infant observation score, a leukocyte count of fewer than 15,000 WBC/mm 3 , a band-toneutrophil ratio of less than 0.2, urinalysis with fewer than 10 leukocytes per high-powered field and no bacteria seen on Gram stain, cerebrospinal fluid (CSF) with fewer than 8 WBC/mm 3 , and a chest radiograph without infiltrate. All but one infant in this low-risk group was documented to have nonbacterial disease.
These two studies illustrate that in children older than 28 days but younger than 3 months, the risk of SBI in well-appearing infants who have reassuring screening tests is low, and discharge home with or without antibiotics is safe. The Philadelphia criteria included the infant observation score, band-to-neutrophil ratio, and an abnormal leukocyte count of fewer than 15,000/mm 3 . By using these more conservative screening criteria, this particular protocol has been effective in eliminating the need for empiric antibiotics.
Because these two emergency room protocols have been successful in the management of fever in infants older than 28 days, Kadish et al. [5] in Salt Lake City retrospectively reviewed infants aged 1-28 days with a temperature of 38°C or greater. The goal of this study was to determine the applicability of the outpatient management protocols for febrile infants aged 1 to 2 months (as used in the Boston and Philadelphia protocols) to febrile infants aged 1-28 days. A retrospective chart review was performed, and criteria from the two previous management protocols were applied to this younger cohort for screening SBI. SBI here was defined as bacterial growth in at least one culture of blood, CSF, urine, stool,or any aspirated fluid. SBI occurred in 45 (12%) of the 372 infants enrolled. Thirty-two infants (8.6%) of the total enrolled had a UTI, 12 (3.2%) had bacteremia, 5 (1.3%) had bacterial meningitis, 3 (0.8%) had cellulitis, 1 (0.3%) had septic arthritis, 1 (0.3%) had bacterial gastroenteritis, and 1 (0.3%) had pneumonia. Ten infants had more than one SBI. Of the enrolled patients, 231 (62%) met Boston's criteria for low risk, of which 8 (3.5%) would have been sent home with an SBI. Half (186 patients) would have met the Philadelphia criteria for low risk for bacterial disease, and of those, 6 (3.2%) would have been sent home with an SBI. These data suggest that current outpatient management protocols for febrile infants would result in 3% of febrile infants aged younger than 28 days being sent home with an SBI, an unacceptable rate. These results support current recommendations that all febrile infants aged younger than 28 days be admitted for parenteral antibiotic treatment and observation until further guidelines with better sensitivities can be constructed.
Urinary tract infection is a frequent SBI in infants aged younger than 2 months. A study conducted by Lin et al. [6] in Taipei, Taiwan, looked at UTI as a source of fever in infants aged younger than 8 weeks. Previous studies [7-9] have linked laboratory signs of inflammation and infection to UTI. The primary objective of Lin's study was to assess the usefulness of these parameters (including peripheral leukocyte count and differential, C-reactive protein concentration, erythrocyte sedimentation rate, microscopic urinalysis, and hemocytometer leukocyte counts) for predicting the presence of UTI. Lin et al. [6] documented UTI in13.6% of febrile infants aged younger than 8 weeks. A standard microscopic urinalysis is often performed on centrifuged specimens. Performing a microscopic analysis on uncentrifuged urine by using a hemocytometer, and reporting cells per mm 3 , is thought to be more sensitive and specific for UTI. The investigation showed that infants with Creactive protein concentration less than 20 and erythrocyte sedimentation rate greater than 30 were at risk for UTI, but peripheral leukocyte count greater than 15,000 was not significantly associated with UTI. Hemocytometer leukocyte count of more than 10 WBC/µl was a significantly better predictor of UTI in febrile infants than were C-reactive protein, erythrocyte sedimentation rate, and standard urinalysis. The usefulness of this information is unknown because most pediatric offices are not equipped to perform this test.
Kupperman's review [10••] of occult bacteremia in young febrile children defines occult bacteremia as the condition in which bacteremia is identified in patients without clinical evidence of sepsis or a toxic appearance. Also, patients cannot have any underlying medical condition or clear focus of infection on physical examination and must have been discharged to home after outpatient evaluation. His goal was to answer the following questions: How commonly does occult bacteremia occur, and what is its natural history? Which, if any, clinical features or screening tools help to detect occult bacteremia? Do empiric antibiotics prevent the sequelae of occult bactermia? What are the costs and benefits of empiric antibiotics in the treatment of young febrile children at risk for occult bacteremia? By addressing each organism individually, Kupperman investigates epidemiology, natural history of disease, screening laboratory tests, outcomes of children receiving empiric antibiotic treatment, and current algorithms for the diagnoses and management therapies of Streptococcus pneumoniae, Neisseria meningitides, and Salmonella species.
Although episodes of occult bacteremia resolve without intervention, serious diseases with adverse consequences do occur, such as meningitis, which can cause deafness, neurologic deficits, or death. The prevalence of S. pneumoniae bacteremia in children aged 3 to 36 months is between 1.4% and 2.5%. The incidence is higher in children aged younger than 2 years and in those who attend daycare centers. In the US there is a bimodal distribution wherein peaks occur between September and February and between April and May. Although N. meningitides is less common, with a prevalence estimated to be 0.025% in children aged 3 to 36 months who have a temperature above 39°C, 25 to 50% of these children with bacteremia are sent home after evaluation in the emergency room setting. Children aged younger than 2 years are also at higher risk, and seasonal variation differs by region.
The evaluation of febrile young infants who appear healthy continues to be debated. With a prevalence of 2 to 3 % of occult bacteremia, most of which cases improve without intervention, the benefits of screening tests and empiric antibiotics must be weighed against costs of tests, painful procedures, risk of false positive results, and increasing antibiotic resistance. With the recent development of the S. pneumoniae conjugate vaccine, current practice for evaluation of fully immunized febrile young children may change.
Managing serious bacterial infection
Many patients are evaluated in the emergency room for SBI and are sent home after receiving a dose of antibiotics, either parenteral or oral. A study by Bachur and Harper [11] examined the reevaluation of patients with blood cultures positive for S. pneumoniae bacteremia. A retrospective review of outpatients with pneumococcal bacteremia was performed, excluding those patients not immunocompetent, those with focal bacterial infections identified at the initial visit, and those admitted at the first evaluation. From these data, a decision tree analysis was used to predict those children at risk for persistent bacteremia. A total of 548 episodes of pneumococcal bacteremia was studied: 73 children received no antibiotics, 239 received oral antibiotics, and 236 received parenteral antibiotics. Median age, leukocyte count, and rectal temperature were 13.5 months, 20,400 WBC/mm 3 , and 40°C, respectively. At follow-up examination, 41 patients had persistent bacteremia or new focal infections, and 8 patients had meningitis. Ninety-two percent returned after notification of a positive blood culture, 2% returned because of parental perceptions of increased severity of illness, and 6% returned at scheduled follow-up evaluation. Repeat blood cultures were obtained in 92% of this cohort: 23% had a lumbar puncture, 33% had a chest radiograph, and 12% were admitted. Patients who did not receive antibiotics or who were treated with oral antibiotics were at highest risk for subsequent bacteremia.
This study suggests clinical reevaluation for all patients with a reported blood culture growing S. pneumoniae. Those who appear ill at follow-up examination require blood culture, lumbar puncture, and hospital admission for parenteral antibiotics. For an infant older than 12 months, who appears well, has a temperature of more than 38°C, and who received either oral or parenteral antibiotics at the first presentation, it may be safe to repeat the blood culture, consider lumbar puncture, and treat the infant with a dose of intramuscular ceftriaxone as an outpatient. If the patient is aged younger than 12 months, appears well, but is still febrile at 38°C or higher, a lumbar puncture should be strongly considered along with either intramuscular ceftriaxone or admission for parenteral antibiotics. If the patient is afebrile at reevaluation (with temperature <38°C), and the patient did not receive antibiotics initially, a repeat blood culture should be obtained and a course of 7 to 10 days of oral antibiotics should be prescribed. If a dose of antibiotics was given, there is no need to repeat the blood culture, but a course of oral antibiotics should be given.
The time it takes for a blood culture to turn positive affects a physician's level of comfort in discharging well-appearing children with fever. McGowan et al. [12] studied the time to positivity by using a continu-ously monitoring blood culture system on a prospective collection of blood cultures taken in the emergency room and outpatient clinics in 47 months. During that time, 10,200 blood cultures were obtained, 711 (6.97%) of which were positive. The mean age at collection was 2 years. A total of 258 cultures (36.3%) contained pathogens only, 370 (52%) contained skin contaminants only, and 83 (11.7%) contained a mixture of both. Of the 258 containing pathogens only, 14% were positive by 12 hours, 87% by 24 hours, 92% by 36 hours, 95% by 48 hours, 98% by 60 hours, and 99.7% by 72 hours. Ninety-five percent of critical pediatric pathogens were detected in fewer than 24 hours, including S. pneumoniae, Salmonella, and other enterobacteriaciae, N. meningitides, and groups A and B streptococci. This information can be useful when making decisions about ongoing empiric antibiotic therapy or length of hospital stay.
The previously reviewed studies investigated fever in the emergency room setting. Finkelstein et al. [1] performed a retrospective cohort study to describe the epidemiology, treatment, and outcomes of children with fever in ambulatory pediatric primary care practices. A cohort of 20,585 children aged between 3 and 36 months cared for in 11 pediatric offices between 1991 and 1994 was reviewed. All visits of a random sample of 5000 children with a temperature higher than 38°C were analyzed, including laboratory tests performed, antibiotics prescribed, and diagnoses conferred. The study included in-person and telephone follow-ups after visits for fever. Hospital claims were reviewed to identify cases of meningitis, meningococcal sepsis, and death from infection. Among 3,819 index visits, 41% had no diagnosed bacterial or specific viral source. However, 56% of febrile children with temperature >39°C were diagnosed with bacterial disease; otitis media was the most common diagnosis (48%). An antibiotic was prescribed for 56% of index visits. Almost all (93%) patients diagnosed with a bacterial disease were treated with antibiotics, and 9% of those diagnosed with a viral process were also given antibiotics. Of those with no identifiable bacterial source, 13% with a temperature of 38 to 39°C and 36% with a temperature of more than 39°C received laboratory testing. Fortythree percent of this subset received some documented follow-up care in the subsequent week. Among the 26,970 child years of observation in the cohort, 15 children (0.06%) were treated for bacterial meningitis or meningococcal sepsis. This study relies on the clinical diagnoses made by each provider but is unable to validate individual diagnoses. For example, otitis media was a common diagnosis and was presumed to be bacterial in origin. It is known that some cases of otitis are caused by viral agents, so this may alter the data regarding appropriateness of antibiotic use.
The presence of high fever in the setting of an erythematous tympanic membrane is linked to S. pneumoniae in a study conducted by Rodriquez and Schwartz [13] . As many as two thirds of all children will have had one or more episodes of acute otitis media by their second birthday. The most common bacterial culprits are S. pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. With the increase of antimicrobial resistance and because differentiating which organism is responsible for infection by physical examination is difficult, antibiotic choice remains difficult. This study enrolled 224 pediatric patients with acute otitis media and no previous antibiotic exposure in the preceding week. Bacterial pathogens were recovered by tympanocentesis in 95% of these patients. S. pneumoniae was recovered in 85 patients (38%), H. influenzae in 62 (28%), and M. catarrhalis in 50 (22%), accounting for 88% of patients. Interestingly, significantly more patients with S. pneumoniae had red, bulging tympanic membranes and temperatures higher than 38.3°C than did those with M. catarrhalis or H. influenzae. This information may be useful as the management of acute otitis media becomes increasingly more difficult in the setting of antibiotic resistance to amoxicillin, the current first-line therapy.
Although the results of this study showed a surprisingly high incidence of bacterial disease in otitis media, they may help pediatricians choose between antibiotics based on height of fever and degree of erythema.
How good are physicians at detecting fever? Is this something that physicians can recognize with a thorough history and physical examination? A recent prospective, observational study [14] evaluated the physician's ability to recognize the presence of fever, as well as anemia and jaundice, in patients. The authors used a convenience sample of patients who presented to the emergency room with a documented rectal temperature no more than 30 minutes before the observation by a physician. The observers, including attending physicians, resident physicians, and rotating medical students, estimated serum hematocrit, bilirubin, and rectal temperature. The physicians were able to detect the presence or absence of fever, anemia, and hyperbilirubinemia with a sensitivity and specificity of 70%. For fever, 95 clinicians made 201 observations of 64 patients. Most of the reports stated that the forehead was the easiest site at which to detect fever. The specificity approached 100% when the patient's temperature was more than 103°F. In previous studies, parents have demonstrated sensitivities of 74 to 90% and specificities of 73 to 98% [15] [16] [17] in detecting fever in their children.
In the study of physicians by Hung et al. [14] , sensitivities and specificities were somewhat lower. This finding suggests that parents may be better able to incorporate other clinical signs (ie, level of activity) in making a decision about the presence of fever in their children.
Diagnosis and management of urinary tract infection
The likelihood of UTI is important to choosing diagnostic testing and empiric treatment. Gorelick and Shaw [18] used a prospective cohort study to develop a clinical prediction rule with which to identify febrile young girls who may need a urine culture in the evaluation for possible UTI. Their study population included all girls younger than 2 years (N = 1469) who presented to the emergency room with a temperature more than 38.3°C and without clear source on physical examination. The presence of two or more of the following five variables was found to predict UTI: aged younger than 12 months, white race, temperature of 39°C or higher, fever for 2 or more days, and absence of source of fever on physical examination. The presence of at least two of these variables reportedly predicted UTI with a sensitivity of 0.95 and a specificity of 0.31. Gorelick and Shaw concluded that using these screening parameters would lead to identification of 95% of children with UTI and eliminate 30% of unnecessary urine cultures. The authors addressed limitations. First, although the sensitivity of urine dipsticks is 60 to 91% and of enhanced urinalysis is 95%, these methods require a urine specimen. The advantage to the proposed decision rule is that no specimen is required. A limitation is that the results need to be validated in a larger study population. The authors stated that the incidence of febrile UTIs (17.8%) in their population was similar to a study conducted by Hoberman and Wald [19] in Pittsburgh (16.9%). Does this study suggest that every white girl aged younger than 1 year with fever must be seen and a urine culture must be obtained? More likely, the study may help guide the clinician in determining a population at higher risk for UTI and may reduce the need to collect urine on those young girls who do not meet high-risk criteria.
The clinical concern for diagnosing UTIs in children is not only to speed recovery with the acute illness but also to reduce the long-term sequelae that are associated with pyelonephritis, including renal scarring, hypertension, and ultimately renal failure. Wennerstrom et al.
[20] performed a population-based cohort study to investigate renal scarring in children with UTI. They enrolled 1221 children (81% girls, median age 3.4 years) with their first symptomatic UTI; 652 had fever and 753 were evaluated by urography. Renal scarring was classified as primary or acquired, the latter defined as no sign of scarring on initial investigation. Seventy-four children without obstruction were found to have renal scarring, and acquired scarring was identified in 40. Primary scarring was found in 18 of 21 (86%) boys and 16 of 53 (30%) girls. The majority of boys were found to have dilated reflux (67%), but only 23% of girls did. Recurrent UTIs were uncommon in boys, whereas girls with acquired scarring had significantly more febrile recurrences than did girls without scarring. The authors conclude that most boys had primary renal damage, most likely congenital reflux-associated, whereas most girls had acquired scarring related to recurrences of febrile UTI.
Are oral antibiotics as effective as intravenous antibiotics in the management of febrile UTI? A study by Hoberman et al. [21••] looked at 306 patients (90% female) between the ages of 1 month and 24 months with temperature more than 38.3°C, pyuria, bacteriuria, and a positive urine culture from a catheterized specimen. The average duration of fever was 48 hours; 4.2% were found also to have a positive blood culture, and 38% had an abnormal voiding cystourethrogram. The patients were randomly sorted into two groups. One group received intravenous antibiotics (cefotaxime for 3 days or until afebrile) followed by a 14-day course of cefixime (4 mg/kg). The other group received oral cefixime (16 mg/kg, given in the emergency department) followed by a 13-day course of cefixime (8 mg/kg). All patients were evaluated by using renal ultrasonography and voiding cystourethrogram and were followed month to month by telephone contact. Short-term outcome measures included urine culture 24 hours after initiation of treatment and duration of fever. Long-term outcome measures included follow-up evaluation of renal function by dimercaptosuccinic acid, symptomatic reinfection, and cost calculated by total hospital charges.
The results showed that the groups had similar outcomes. All urine was sterile at 24 hours, and duration of fever was not different (24.7 hours for oral antibiotic versus 23.9 hours for intravenous). There was no significant difference in reinfection rates (4.6% oral and 7.2% intravenous) or in renal scarring (9.8% oral and 7.2% intravenous). As expected, management with intravenous therapy and hospital admission (average cost, $3577) was more expensive than outpatient management with oral antibiotics (average cost, $1463). This study provides good evidence that treatment with highdose oral antibiotics for young children with UTI is as effective as management with parenteral antibiotics and is less expensive.
Bachur [22] investigated the premise that resolution of fever in a child with a febrile UTI is a clinical marker of resolution of disease. In an inpatient setting, the decision is often made to discharge a patient after the fever has abated. Bachur's study is a chart review of all children aged younger than 2 years who were admitted with a primary diagnosis of pyelonephritis or UTI during a 65-month period. Nonresponders were defined as those above the 90th percentile for the time needed for fever to abate. These patients were compared with the remainder of patients, termed the responders. The study showed that 89% of patients were afebrile within 48 hours of receipt of parenteral antibiotics. The patients whose fever lasted longer than 48 hours were clinically similar to those who responded more quickly to antibiotics. These data suggest that additional imaging or diagnostic testing for patients based solely on fever after 48 hours may be unnecessary, particularly in the setting of known antibiotic sensitivities.
Conclusions
Recent studies in diagnosis, evaluation, and management of fever in infants and children continue to investigate the clinician's ability to predict serious bacterial infection and determine the most cost-effective and safest therapy. Although it has been found to be safe and effective to evaluate febrile infants older than 28 days with certain screening tests and to discharge those identified as low risk, it has been suggested that those practice guidelines are not safe for use with infants younger than 28 days [5] . A review of occult bacteremia in the era of vaccines for both H. influenzae type B and S. pneumoniae reminds pediatricians of the data supporting the treatment of febrile infants. Moreover, the ability to manage febrile UTI with oral antibiotics on an outpatient basis [21••] would dramatically decrease the need for hospital admissions and obtaining intravenous access and would reduce family stress surrounding hospital care. Although many questions remain, investigators continue to improve the ability of clinicians to diagnose and manage the common problem of fever in children.
